Chronic Myelogenous Leukemia

Filter By:
Filmed at the 2014 Great Debates and Updates in Hematologic Malignancies Congress in New York, this online activity is comprised of three videos wherein Dr. James M. Epstein is joined by Drs. Robert Z. Orlowski, David P. Steensma, and John P. Leonard to discuss recent clinical advances in hematologic malignancies. This engaging conversational forma...
by:imedex | 80 views
A healthy relationship between a chronic lymphocytic leukemia (CLL) patient and their healthcare team can help ensure that they receive the best care possible. A key member of that team is a nurse practitioner, who often plays an important role in the communication between patients and physicians. Lisa Nodzon , who is an advanced registered nurse p...
by:patientpower | 184 views
Der münchner Patienten Vertreter Jan Geissler, nahm an CML Aufklärungssitz​ungen eines Experten-Treffe​ns in New Orleans teil. Er hat folgendes zu berichten.
by:patientpower | 192 views
How do a CML diagnosis and a patient's stage guide treatment? Dr. Jorge Cortes, a leading researcher from MD Anderson Cancer Center, reviews CML treatment options and explains approaches for patients who don't respond initially to treatment (primary resistance) or stop responding (secondary resistance). Made possible through an educational grant...
by:patientpower | 255 views
Antibody-drug conjugates or ADCs represent an innovative therapeutic application that combines the unique properties of monoclonal antibodies (mAbs) with the potent cell killing activity of cytotoxic small molecule drugs. The key components of antibody-drug conjugates include a monoclonal antibody (mAbs), a stable linkers and a cytotoxic (anti...
by:ADCReview | 921 views
While targeted drug therapies have proven effective for most patients diagnosed with Chronic Myelogenous Leukemia (CML), some patients encounter clinical issues that cause them to lose their response to treatment. What happens then? CML expert Dr. Michael Mauro addresses the question, and shares the...
by:patientpower | 2333 views
With an annual $100,000+ cost for current treatment options, physicians treating Chronic Myelogenous Leukemia (CML) patients have raised questions about whether these price levels are sustainable. In a recent article in "Blood," the journal of the American Society of Hematology, 100+ physi...
by:patientpower | 2405 views
Jeffrey Lipton discusses news from ASCO 2012 about how Tasigna could bring faster and deeper responses, taking some newly diagnosed patients all the way to Complete Molecular Response (CMR) well within the first year of therapy. Dr. Lipton explains that the focus in Chronic Myelogenous Leukemia (CML...
by:patientpower | 1287 views
A promising new treatment brings hope for patients with a rare form of leukemia who have run out of treatment options. Results reported for a third-line treatment for Chronic Myelogenous Leukemia (CML) show the investigational drug, ponatinib, helped patients with relapsed or resistant response to p...
by:patientpower | 1202 views
Imagine having routine pre-surgery blood work then being told you have Chronic Myelogenous Leukemia (CML). Your whole world is quickly turned upside down. This surreal experience happened to Erin Havel 5 years ago. In this program, Erin and her hematologist/on​cologist Dr. Michael Milder, from the Sw...
by:patientpower | 960 views

Top Tags

Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Different type of MD 
Other oncology Professional 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.

username:   password: remember me

Sign In

Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)